Patients
Doctors
En el Hospital Metropolitano se realizó la primera Ablación por Pulsos Eléctricos (PFA) en Quito.
San Patricio Metropolitan Hospital begins construction of its new headquarters with innovation and sustainability in healthcare.
Quito, August 2025.- With an approximate investment of $95 million, the Metropolitan Hospital began construction of its new headquarters in the San Patricio Smart Living urban development project, a hospital complex that will mark a milestone for medical care in the country. Its strategic location seeks to bring excellent healthcare services to communities in the Quito valleys such as Cumbayá, Tumbaco, Puembo, and the Valle de los Chillos, responding to population growth and the need to guarantee timely and specialized care in that area.
The hospital will have 75 hospital beds, 14 emergency cubicles, 13 intensive care beds, and six smart operating rooms, in addition to two medical towers with more than 300 consulting rooms. It will be a tertiary-level general hospital, equipped to handle highly complex cases and emergencies with the support of more than 30 medical specialties. During its construction, it will generate approximately 800 direct and indirect jobs.
The 50,500 m² facility, spread over nine levels, was designed under the international EDGE (Excellence in Design for Greater Efficiencies) standards, which certify green buildings. This means the hospital will achieve at least 20% savings in water, energy, and materials consumption, thanks to the integration of natural light, efficient air conditioning systems, responsible water management, and the use of materials with a lower carbon footprint.
The new San Patricio campus will maintain the same high-quality, cutting-edge standards as the Quito Metropolitan Hospital. It will feature advanced medical equipment for diagnosis and treatment, smart operating rooms, integrated digital systems for clinical management and monitoring, and energy and water efficiency solutions that optimize flows and processes. Additionally, the Quito campus will continue to house the Da Vinci robotic surgery and the Comprehensive Cancer Center.
With this new location, we expand our care capacity in an area that requires a friendly and excellent hospital model. Patients and their families have placed their trust in us for over 40 years; now, we want to reciprocate and bring a new Metropolitan Hospital to this important area of Quito.
The hospital infrastructure will prioritize the experience of patients and their families, with consulting rooms with immediate access to the Emergency Department for rapid medical resolution, as well as the peace of mind and convenience of having doctors nearby. But beyond the infrastructure and medical technology, this project reinforces the standards of the Metropolitan Hospital, recognized for its international quality and safety accreditations, as well as its humane treatment and prestigious medical staff.
The opening of this new Hospital is estimated for December 2026.
About Metropolitan Hospital
Since 1977, Metropolitan Hospital has been a comprehensive healthcare system that has distinguished itself by providing the highest quality, safety, and compassionate care, based on an organizational culture centered on humane and personalized treatment. Its commitment to the well-being of patients and their families has led it to lead the transformation of healthcare services through innovation in state-of-the-art processes, equipment, and infrastructure. All of this is supported by a team of professionals who meet the highest standards. It is the first private hospital in the country to perform surgical interventions using the Da Vinci robot for all ages.
Press Contact
Leonel Llumitaxi
Account Executive, MC Communications
Email: lllumitaxi@mccomunicaciones.com.ec
Telephone: 0995981823
Pacientes con neuralgia del trigémino ya pueden acceder a radiocirugía no invasiva en el país
Las personas que viven con neuralgia del trigémino, una de las condiciones más dolorosas del sistema nervioso, ya no tendrán que viajar fuera del país para acceder a una alternativa terapéutica avanzada. Por primera vez en el Ecuador, en el Hospital Metropolitano, se realizó una radiocirugía funcional sobre el nervio trigémino, abriendo una nueva posibilidad de tratamiento para quienes no responden a medicamentos y enfrentan un deterioro severo en su calidad de vida.
La intervención fue realizada mediante un sistema de radiocirugía estereotáxica de alta precisión con acelerador lineal, que permite tratar el foco del dolor sin necesidad de cirugía abierta, cortes, ni anestesia general. Se trata de un procedimiento ambulatorio, seguro y no invasivo que ha cambiado el enfoque terapéutico para pacientes con neuralgia refractaria.
Un dolor invisible, pero incapacitante
La neuralgia del trigémino es un trastorno neurológico crónico que provoca dolor facial extremo, repentino y punzante, descrito por los pacientes como una descarga eléctrica intolerable. Puede desencadenarse por acciones tan simples como hablar, cepillarse los dientes o sentir una brisa en el rostro.
A pesar de ser poco conocida, esta condición tiene un impacto devastador en la vida diaria de quienes la padecen. Hasta ahora, las opciones para casos severos en el país eran limitadas, y muchos pacientes se veían obligados a buscar tratamiento quirúrgico en el exterior.
Radiocirugía: precisión milimétrica sin bisturí
A diferencia de una cirugía convencional, la radiocirugía no implica cortes ni hospitalización. El paciente se somete a una única sesión ambulatoria, durante la cual se le administra una dosis precisa de radiación directamente sobre el nervio trigémino. El procedimiento es indoloro y su objetivo es desactivar el área del nervio que está generando el dolor.
Este tipo de intervención es posible gracias al trabajo coordinado de un equipo médico altamente especializado y a la disponibilidad de un acelerador lineal de última generación, que permite alcanzar niveles de precisión submilimétrica.
“Esta técnica representa un gran avance, ya que ofrece una alternativa segura y eficaz para pacientes con neuralgia del trigémino que no responden a tratamientos farmacológicos o que no pueden ser sometidos a cirugía abierta”, explica el Dr. Raúl Puente Vallejo, radioncólogo y jefe de la Unidad de Radioterapia del Hospital Metropolitano.
Dr. Raúl Puente
JEFE DE LA UNIDAD DE RADIOTERAPIA
HOSPITAL METROPOLITANO
En el Hospital Metropolitano se realizó la primera Ablación por Pulsos Eléctricos (PFA) en Quito.
El Hospital Metropolitano ha realizado, por primera vez, dos procedimientos de alta complejidad en el tratamiento oncológico no invasivo: una radiocirugía cerebral estereotáxica y una radioterapia ablativa corporal estereotáxica (SBRT) hepática, consolidando nuestro liderazgo en medicina de precisión.
La radiocirugía cerebral fue realizada en una paciente de 37 años, quien presentaba cuatro lesiones tumorales en cerebro y cerebelo. El procedimiento se llevó a cabo de forma ambulatoria, sin secuelas, con una exactitud submilimétrica de 0,3 mm en cada una de las lesiones tratadas.
Esta intervención fue posible gracias a nuestro acelerador lineal de última generación, con capacidades técnicas equivalentes a las de un Gamma Knife, al que se suma la verificación tridimensional del volumen a tratar y una dosimetría de radiación específica para campos pequeños y submilimétricos.
Por otra parte, el tratamiento de radioterapia ablativa hepática fue aplicado a un paciente de 67 años, con un hepatocarcinoma previamente manejado con técnicas de intervencionismo, sin resultados satisfactorios. Este caso fue evaluado en nuestra junta médica oncológica, que determinó la idoneidad del tratamiento con SBRT.
Gracias a nuestras micromultiláminas y al sistema de seguimiento ventilatorio, logramos entregar la radiación únicamente cuando la lesión hepática se encontraba dentro de un rango específico de movimiento respiratorio, minimizando la irradiación de tejido sano y aumentando la seguridad del procedimiento.
Tanto la radiocirugía como la SBRT representan opciones terapéuticas eficaces para el control de lesiones metastásicas o tumores considerados inoperables por su localización. Su implementación permite mejorar la calidad de vida de los pacientes, prolongar la sobrevida libre de síntomas e incluso la sobrevida global.
Estos avances fueron posibles gracias al compromiso de nuestro equipo médico altamente calificado y a la tecnología más avanzada disponible en el país. En el Hospital Metropolitano reafirmamos nuestro compromiso con una medicina de vanguardia, segura y centrada en brindar nuevas oportunidades a nuestros pacientes.
Dr. Raúl Puente
JEFE DE LA UNIDAD DE RADIOTERAPIA
JEFE DE LA UNIDAD DE RADIOTERAPIA
HOSPITAL METROPOLITANO
Primeros procedimientos de radiocirugía cerebral y radioterapia ablativa corporal estereotáxica realizados en el Hospital Metropolitano
El Hospital Metropolitano ha realizado, por primera vez, dos procedimientos de alta complejidad en el tratamiento oncológico no invasivo: una radiocirugía cerebral estereotáxica y una radioterapia ablativa corporal estereotáxica (SBRT) hepática, consolidando nuestro liderazgo en medicina de precisión.
La radiocirugía cerebral fue realizada en una paciente de 37 años, quien presentaba cuatro lesiones tumorales en cerebro y cerebelo. El procedimiento se llevó a cabo de forma ambulatoria, sin secuelas, con una exactitud submilimétrica de 0,3 mm en cada una de las lesiones tratadas.
Esta intervención fue posible gracias a nuestro acelerador lineal de última generación, con capacidades técnicas equivalentes a las de un Gamma Knife, al que se suma la verificación tridimensional del volumen a tratar y una dosimetría de radiación específica para campos pequeños y submilimétricos.
Por otra parte, el tratamiento de radioterapia ablativa hepática fue aplicado a un paciente de 67 años, con un hepatocarcinoma previamente manejado con técnicas de intervencionismo, sin resultados satisfactorios. Este caso fue evaluado en nuestra junta médica oncológica, que determinó la idoneidad del tratamiento con SBRT.
Gracias a nuestras micromultiláminas y al sistema de seguimiento ventilatorio, logramos entregar la radiación únicamente cuando la lesión hepática se encontraba dentro de un rango específico de movimiento respiratorio, minimizando la irradiación de tejido sano y aumentando la seguridad del procedimiento.
Tanto la radiocirugía como la SBRT representan opciones terapéuticas eficaces para el control de lesiones metastásicas o tumores considerados inoperables por su localización. Su implementación permite mejorar la calidad de vida de los pacientes, prolongar la sobrevida libre de síntomas e incluso la sobrevida global.
Estos avances fueron posibles gracias al compromiso de nuestro equipo médico altamente calificado y a la tecnología más avanzada disponible en el país. En el Hospital Metropolitano reafirmamos nuestro compromiso con una medicina de vanguardia, segura y centrada en brindar nuevas oportunidades a nuestros pacientes.
Dr. Raúl Puente
JEFE DE LA UNIDAD DE RADIOTERAPIA
JEFE DE LA UNIDAD DE RADIOTERAPIA
HOSPITAL METROPOLITANO
El Hospital Metropolitano se suma a las iniciativas de sostenibilidad con energía solar
Quito 26 de noviembre, 2024
Introducción: Alineados con el compromiso con la sostenibilidad, el Hospital Metropolitano ha dado un paso significativo hacia la innovación energética con la implementación de un sistema de paneles solares. En una primera fase, ya concluida, se han instalado 650 paneles solares en los techos del edificio principal, logrando cubrir al menos el 10% de las necesidades energéticas del Hospital.
Desarrollo: El proyecto contempla una segunda fase para 2025, que incluirá la instalación de una granja solar en el sector de Pifo, diseñada para abastecer el 90% de la energía requerida por el Hospital Metropolitano. Este esfuerzo reafirma su compromiso con la reducción de la huella de carbono en el sector salud y con el desarrollo de modelos más sostenibles.
Declaración destacada: “Este proyecto es una muestra de nuestro compromiso con el cuidado del planeta y la innovación. Estamos avanzando hacia un modelo más sostenible, generando un impacto positivo para el medio ambiente”, destacó el Ing. Alejandro Calisto, director de Infraestructura y Logística del Hospital.
Además, en agosto de este año el Hospital Metropolitano obtuvo la certificación Carbono Neutro, un reconocimiento que valida sus esfuerzos por medir, reducir y compensar las emisiones de gases de efecto invernadero que pudieran ser generadas por sus operaciones. Esta certificación resalta el compromiso de sumarse a las iniciativas que impacten positivamente en el entorno y en la comunidad.
Cierre: El uso de energía solar no solo optimiza la eficiencia energética, sino que también genera importantes beneficios ambientales. El Hospital Metropolitano continuará trabajando para integrar tecnologías limpias en sus operaciones, demostrando que la excelencia médica puede ir de la mano con el respeto por el entorno.
The first robotic cardiac surgery was performed at the Metropolitan Hospital
The first Da Vinci Xi robot-assisted total pericardiectomy surgery was performed at the Metropolitan Hospital. This surgical procedure was used to decompress the heart that was wrapped in a layer called the parietal pericardium and is the first in Ecuador and the fourth in Latin America.
Thanks to this avant-garde and minimally invasive technology, the patient will feel less pain in the postoperative period, he will have a much faster, almost immediate recovery, which will restore his vitality, indicated Dr. Óscar Eskola, a robotic cardiothoracic surgeon who carried out this medical milestone in the country and the Hospital.
Before this procedure, the patient presented several symptoms of pain and difficulty breathing, which made his daily activities impossible. His level of exhaustion did not even allow him to carry out his daily chores.
The difference between this robot-assisted surgery and a traditional one is that in robotics the procedure is performed by entering with minimal incisions on the sides of the thorax (left and right), to attack the two fronts of the pericardium and obtain total decompression of this organ, while, in traditional surgery it is performed through a sternotomy, which is a large opening in the sternum and is opened conventionally to release the pericardium. Its recovery is much more extensive and its approach is totally invasive.
The robotic technology used in cardiothoracic procedures facilitates the treatment of pathologies in the lung, thymus and other complex areas, offering great benefits to the patient during surgery and in their subsequent recovery.
Dr. Oscar Eskola
CARDIOTHORACIC SURGEON
CARDIOTHORACIC SURGEON
METROPOLITAN HOSPITAL
IFC grants US$25 million loan to Grupo Conclina to promote health services in Ecuador
The International Finance Corporation (IFC), a member of the World Bank Group, granted a loan for US$25 million to Grupo Conclina for the construction of a new hospital in Cumbayá, in a new urban growth area located to the east of Quito, in order to promote more affordable and high-quality health services in Ecuador.
The loan to Grupo Conclina, Ecuador's leading health services organization, will also be directed toward upgrades to existing infrastructure, including the implementation of its digital transformation. This is IFC's third financing to Grupo Conclina, identified as a strategic client given its strong demonstration effect in Ecuador, driven mainly by the institution's high quality standards. Since 2022, Grupo Conclina has been part of IFC's Digital Global Health Platform (DigiHealth), which encompasses tools to plan, prioritize, finance and implement successful digital transformation strategies.
Ecuador's healthcare system is struggling to keep up with the growing demand for quality healthcare services and specialized care, exacerbated during the COVID-19 pandemic. According to the National Institute of Statistics and Censuses (INEC), Ecuador has only 1.4 beds per 1,000 inhabitants, a figure below the regional average of 1.9 and the global average of 2.7. Given the limited public resources available for health services, the private sector can play a key role in complementing public capacity by expanding access to specialized care and reducing the direct burden on the public sector.
Matilde Bordón, IFC Country Manager for Peru, Ecuador and Bolivia, assured: "This new loan to Grupo Conclina reaffirms IFC's commitment in the region to make investments and advice that foster best practices in healthcare and promote the deployment of technologies. "We are proud to support Grupo Conclina in its mission to provide Ecuador with affordable and quality medical services."
José Barahona, Chairman of the Board of Directors of Grupo Conclina, said: "We see in this initiative an exceptional opportunity to contribute to the growth of Quito, marking a significant milestone in our commitment to the health and development of the city."
IFC has an active portfolio of $3.5 billion in healthcare companies in emerging markets. Through these investments, IFC supports governments in their goal of achieving Universal Health Coverage by 2030.
About IFC
The International Finance Corporation (IFC), an organization that is part of the World Bank Group, is the leading international development institution dedicated to the private sector in emerging markets. It works in more than 100 countries and uses its capital, expertise and influence to create markets and opportunities in developing countries. In fiscal 2023, IFC committed a record $43.7 billion to private companies and financial institutions in developing countries, seeking to harness the capacity of the private sector to help end extreme poverty and promote shared prosperity as economies address the impacts of simultaneous global crises.
About Conclina Group
Grupo Conclina, a leader in Ecuador's private health market that currently has a total turnover of USD 175 million and has assets of USD 120 million, has been a beacon of excellence and care in the healthcare landscape since its inception in 1985. private in Ecuador, is the owner of the Metropolitan Hospital, which is not only the largest private hospital in the country, but also manages the highest quality standards on international scales.
Grupo Conclina goes beyond the walls of a hospital, guaranteeing a comprehensive medical system through Humana SA, a company that manages the prepaid medicine division, and Metrored, a company dedicated to outpatient care and telemedicine, mainly in Quito and Guayaquil. , thus testifying to a solid and firm commitment to accessibility and innovation in medical care for the benefit of thousands of Ecuadorians.
" A person with heart disease can have a normal life, but parents and families must be aware that they need periodic pediatric and cardiological monitoring, daily care and hygiene to avoid infections that can lodge in the heart, such as "dental "
Accredited for the 5th time!
The Metropolitan Hospital has been reaccredited by the prestigious organization Joint Commission International (JCI). This gold seal confirms our unwavering commitment to quality and safety in medical care, being the only hospital in Ecuador to achieve this important recognition.
The Joint Commission International is a global organization dedicated to improving the quality of healthcare through rigorous evaluation and certification processes. The JCI establishes standards of excellence that hospitals must meet to obtain this accreditation, evaluating critical aspects such as patient safety, treatment effectiveness, risk management and continuing education of medical staff.
Since 2011, the Metropolitan Hospital has been a benchmark in the country, consistently demonstrating that we are at the forefront of medical care. Each JCI accreditation represents hard work and dedication from our entire team to ensure our patients receive the best care possible.
This recognition is not only a testament to our commitment to excellence, but also an endorsement to our patients that they are receiving medical care that meets the highest international standards of safety and quality. The trust you place in us is our greatest motivation to continue improving and offering quality health services.
" A person with heart disease can have a normal life, but parents and families must be aware that they need periodic pediatric and cardiological monitoring, daily care and hygiene to avoid infections that can lodge in the heart, such as "dental "
For more information about the Joint Commission International and its standards, we invite you to visit its official website www.jointcommissioninternational.org.